Livforsakringsbolaget Skandia’s Bristol-Myers Squibb BMY Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$954K	Hold	15,732	–	–	0.04%	169
2025 Q4	$849K	Hold	15,732	–	–	0.03%	189
2025 Q3	$709K	Sell	15,732 -700	-4%	-$32.7K	0.03%	206
2025 Q2	$760K	Hold	16,432	–	–	0.03%	210
2025 Q1	$1M	Hold	16,432	–	–	0.06%	193
2024 Q4	$929K	Sell	16,432 -800	-5%	-$44.7K	0.05%	196
2024 Q3	$892K	Buy	17,232 +13,664	+383%	+$641K	0.05%	207
2024 Q2	$148K	Sell	3,568 -103,500	-97%	-$4.63M	0.01%	249
2024 Q1	$5.81M	Hold	107,068	–	–	0.49%	56
2023 Q4	$5.49M	Buy	107,068 +1,962	+2%	+$103K	0.52%	51
2023 Q3	$6.1M	Sell	105,106 -4,800	-4%	-$294K	0.67%	42
2023 Q2	$7.03M	Sell	109,906 -11,000	-9%	-$738K	0.73%	34
2023 Q1	$8.38M	Hold	120,906	–	–	0.88%	27
2022 Q4	$8.7M	Hold	120,906	–	–	1%	20
2022 Q3	$8.6M	Sell	120,906 -27,300	-18%	-$1.98M	1.06%	16
2022 Q2	$11.4M	Sell	148,206 -7,500	-5%	-$571K	0.99%	20
2022 Q1	$11.4M	Hold	155,706	–	–	0.76%	28
2021 Q4	$9.71M	Sell	155,706 -11,100	-7%	-$651K	0.62%	35
2021 Q3	$9.87M	Buy	166,806 +11,500	+7%	+$757K	0.62%	32
2021 Q2	$10.4M	Buy	155,306 +13,600	+10%	+$887K	0.62%	32
2021 Q1	$8.95M	Buy	141,706 +16,900	+14%	+$1.05M	0.62%	37
2020 Q4	$7.74M	Buy	124,806 +9,300	+8%	+$572K	0.66%	32
2020 Q3	$6.96M	Buy	115,506 +1,600	+1%	+$96.3K	0.75%	27
2020 Q2	$6.7M	Buy	113,906 +400	+0.4%	+$23.9K	0.77%	26
2020 Q1	$6.33M	Buy	113,506 +60,100	+113%	+$3.67M	0.89%	21
2019 Q4	$3.43M	Sell	53,406 -2,800	-5%	-$160K	0.41%	69
2019 Q3	$2.85M	Buy	56,206 +700	+1%	+$32.9K	0.34%	81
2019 Q2	$2.52M	Buy	55,506 +2,000	+4%	+$93.2K	0.31%	87
2019 Q1	$2.55M	Sell	53,506 -20,500	-28%	-$1.02M	0.34%	77
2018 Q4	$3.85M	Buy	74,006 +46,600	+170%	+$2.5M	0.58%	42
2018 Q3	$1.7M	Sell	27,406 -16,900	-38%	-$1M	0.2%	131
2018 Q2	$2.45M	Buy	44,306 +4,000	+10%	+$216K	0.22%	121
2018 Q1	$2.55M	Hold	40,306	–	–	0.25%	114
2017 Q4	$2.47M	Sell	40,306 -15,900	-28%	-$995K	0.24%	117
2017 Q3	$3.58M	Sell	56,206 -7,800	-12%	-$455K	0.32%	84
2017 Q2	$3.57M	Hold	64,006	–	–	0.33%	83
2017 Q1	$3.48M	Sell	64,006 -62,700	-49%	-$3.44M	0.33%	81
2016 Q4	$7.41K	Buy	126,706 +23,951	+23%	+$1.31M	0.38%	49
2016 Q3	$3.57M	Sell	102,755 -83,051	-45%	-$5.33M	0.17%	150
2016 Q2	$13.7M	Buy	185,806 +11,800	+7%	+$834K	0.61%	37
2016 Q1	$11.1M	Hold	174,006	–	–	0.52%	41
2015 Q4	$12M	Buy	174,006 +12,900	+8%	+$852K	0.56%	40
2015 Q3	$9.54M	Buy	161,106 +2,200	+1%	+$140K	0.5%	41
2015 Q2	$10.6M	Hold	158,906	–	–	0.52%	41
2015 Q1	$10.2M	Sell	158,906 -8,900	-5%	-$557K	0.5%	42
2014 Q4	$9.91M	Sell	167,806 -52,300	-24%	-$2.95M	0.46%	44
2014 Q3	$11.3M	Sell	220,106 -18,800	-8%	-$939K	0.43%	45
2014 Q2	$11.6M	Hold	238,906	–	–	0.42%	48
2014 Q1	$12.4M	Buy	+238,906	New	+$12.7M	0.47%	44

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Livforsakringsbolaget Skandia's BMY Position: Q1 2026 in Review

Livforsakringsbolaget Skandia held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 15,732 shares worth $954K. The position accounts for 0.04% of the portfolio, ranked #169.

Livforsakringsbolaget Skandia first reported a position in BMY in Q1 2014 and has held it in 49 quarters since. The position peaked at $13.7M in Q2 2016. 2,528 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Livforsakringsbolaget Skandia held 15,732 shares of Bristol-Myers Squibb worth $954K as of Q1 2026.
Livforsakringsbolaget Skandia left its Bristol-Myers Squibb share count unchanged in Q1 2026.
Bristol-Myers Squibb made up 0.04% of Livforsakringsbolaget Skandia's portfolio in Q1 2026, its #169 holding.
Livforsakringsbolaget Skandia first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 49 quarters since.
Livforsakringsbolaget Skandia's Bristol-Myers Squibb position peaked at $13.7M in Q2 2016.
2,528 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2026, filed 5 May 2026.